Babiloni C. et al. Reactivity of cortical alpha rhythms to eye opening in mild cognitive impairment and Alzheimer's disease: an EEG study .
Babiloni C. et al. Stability of clinical condition in mild cognitive impairment is related to cortical sources of alpha rhythms: An electroencephalographic study .
Balducci C. APP transgenic mice: their use and limitations .
Forloni G. Traslazionale o semplicemente razionale: la ricerca per la malattia di Alzheimer . Ricerca & Pratica 2010 ; n.155 : 183-192.
Frisoni G.B. Alzheimer’s Disease Neuroimaging Initiative in Europe .
Frisoni G.B. et al. The clinical use of structural MRI in Alzheimer disease . Nat. Rev. Neurol. 6, 67–77 (2010).
Lorenzi, M., Donohue, M., Paternicò, D., Scarpazza, C., Ostrowitzki, S., Blin, O., Irving, E., Frisoni, G.B., and the Alzheimer's Disease Neuroimaging Initiative. Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment . Neurobiol Aging. 2010 Aug 31 (8):1443-51. http://www.ncbi.nlm.nih.gov/pubmed?term=Enrichment%20through%20biomarkers%20in%20clinical%20trials%20of%20Alzheimer%27s%20drugs%20in%20patients%20with%20mild%20cognitive%20impairment
Babiloni C. et al. Resting state cortical electroencephalographic rhythms and white matter vascular lesions in subjects with Alzheimer’s disease: an Italian multicentre study . http://www.ncbi.nlm.nih.gov/pubmed/21673406
Babiloni et al., Resting state cortical EEG rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer’s disease: an ADNI project . Human Brain Mapping
Drago V. et al. Disease Tracking Markers for Alzheimer’s Disease at the Prodromal (MCI) Stage . Journal of Alzheimer's disease. http://www4.unitn.it/Ugcvp/en/Web/Prodotto/2147455440
Languille S. et al. The grey mouse lemur: A non-human primate model for ageing studies. Ageing research Review. http://www.ncbi.nlm.nih.gov/pubmed/21802530
Pifferi et al., The sleep-wake cycle in the non-human primate grey mouse lemur (Microcebus murinus): effects of dietary resveratrol supplementation . Chronobiology International
Deguil J. et al. Evaluation of symptomatic drug effects in Alzheimer’s disease: strategies for prediction of efficacy in humans. September 2013. www.sciencedirect.com/science/article/pii/S1740674913000279
Last Updated: mercredi 04 janvier 2012